A Rare Case of Acute Promyelocytic Leukemia with Morphologic Dysplasia and Unique Molecular Characteristics
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Acute promyelocytic leukemia (APL) is a distinct acute myeloid leukemia characterized by abnormal promyelocyte predominance. Typical APL cases rarely present dysplastic changes and disease progression of de novo myelodysplastic syndrome to APL is also very uncommon, which makes APL suspicion difficult in cases with dysplasia. Here, we report a unique case of APL featuring morphologic dysplasia. As for our patient, there were several additional unusual findings: the initial bone marrow examination did not reveal an increase in promyelocytes, but rather showed a modest increase in myeloblasts with normal coagulation profiles and a normal karyotype. Moreover, decrease of initially detected ETV6 mutations as well as new FLT3 mutations were observed on repeated targeted sequencing. The possibility of APL should not be overlooked even at the slightest increase of promyelocytes, and early diagnostic tests for fusion transcripts should be considered.
Abstract
Acute promyelocytic leukemia (APL) is a distinct acute myeloid leukemia characterized by abnormal promyelocyte predominance. Typical APL cases rarely present dysplastic changes and disease progression of de novo myelodysplastic syndrome to APL is also very uncommon, which makes APL suspicion difficult in cases with dysplasia. Here, we report a unique case of APL featuring morphologic dysplasia. As for our patient, there were several additional unusual findings: the initial bone marrow examination did not reveal an increase in promyelocytes, but rather showed a modest increase in myeloblasts with normal coagulation profiles and a normal karyotype. Moreover, decrease of initially detected ETV6 mutations as well as new FLT3 mutations were observed on repeated targeted sequencing. The possibility of APL should not be overlooked even at the slightest increase of promyelocytes, and early diagnostic tests for fusion transcripts should be considered.
참고문헌 (13)
- Castoldi GL, "Acute promyelocytic leukemia : morphological aspects", Leukemia, 8, pp.1441~1446 (1994)
- Wang ZY, "Acute promyelocytic leukemia : from highly fatal to highly curable", Blood, 111, pp.2505~2515 (2008)
- Isono S, "A case of acute promyelocytic leukemia with morphologic multilineage dysplastic changes", Hematol Rep, 5, pp.18~20 (2013)
- Shang H, "Acute promyelocytic leukemia suggesting a diagnosis of myelodysplastic syndrome : a diagnostic dilemma", Clin Lab, 68, pp.1949~1952 (2022)
- Varma N, "Correlation between morphological and cytochemical heterogeneity of acute promyelocytic leukemia(APL)and its association with myelodysplasia", Indian J Cancer, 27, pp.165~171 (1990)
- Hoffmann L, "Therapy-related acute promyelocytic leukemia with t(15;17)(q22;q12)following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature", Ann Oncol, 6, pp.781~788 (1995)
- Wolach O, "Acute promyelocytic leukemia with a smoldering course associated with therapy-related myelodysplastic syndrome", Acta Haematol, 126, pp.152~156 (2011)
- Andersen MK, "Balanced chromosome abnormalities inv(16)and t(15;17)in therapy-related myelodysplastic syndromes and acute leukemia : report from an international workshop", Genes Chromosomes Cancer, 33, pp.395~400 (2002)
- Haferlach T, "Morphologic dysplasia in de novo acute myeloid leukemia(AML)is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy : results of a multiparameter analysis from the German AML Cooperative Group studies", J Clin Oncol, 21, pp.256~265 (2003)
- Gao NA, "Significance of ETV6 rearrangement in acute promyelocytic leukemia with t(15;17)", promyelocytic leukemia, Oncol Lett, pp.2016, 11[DOI]
- Schnittger S, "Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)", PML-RARA, 2011, pp.96, 1799~1807
- Wang Q, "ETV6 mutation in a cohort of 970 patients with hematologic malignancies", Haematologica, 99, pp.e176~e178 (2014)
- Daver N, "FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia", Am J Hematol, 88, pp.56~59 (2013)